Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-27 @ 4:41 AM
Study NCT ID:
NCT00644020
Status:
UNKNOWN
Last Update Posted:
2008-03-26
First Post:
2008-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Sponsor:
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TYS-CN-1.1PUMPⅡPartA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Xiaoping Chen
Old Organization:
Tongji Hospital of Tongji Medical College of HUST